Ticker Details
Apogee Therapeutics, Inc.
IPO Date:	July 14, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.81B
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$1.41 | 3.16%
Avg Daily Range (30 D):	$2.50 | 2.97%
Avg Daily Range (90 D):	$2.07 | 2.66%

Institutional Daily Volume
Avg Daily Volume:	.51M
Avg Daily Volume (30 D):	.78M
Avg Daily Volume (90 D):	.75M

Trade Size
Avg Trade Size (Sh.):	55
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	54

Institutional Trades
Total Institutional Trades:	339
Avg Institutional Trade:	$10.6M
Avg Institutional Trade (30 D):	$10.6M
Avg Institutional Trade (90 D):	$10.6M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	339

Market Closing Trades
Avg Closing Trade:	$76.62M
Avg Closing Trade (30 D):	$76.62M
Avg Closing Trade (90 D):	$76.62M
Avg Closing Volume:	578.04K

News

Jun 24, 2026 @ 1:20 AM Halper Sadeh LLC is Investigating Whether APGE, LP... Source: Halper Sadeh Llc

Jun 22, 2026 @ 10:36 PM AbbVie's $10.9 Billion Apogee Deal Will Extend Its... Source: Eric Volkman

Jun 22, 2026 @ 5:47 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Mar 26, 2026 @ 3:33 PM Apogee CEO Sells 20,000 Shares as Stock Surges Nea... Source: Jonathan Ponciano

Mar 25, 2026 @ 1:53 AM Apogee Therapeutics, Inc. Announces Pricing of $35... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.06	$-1.03	$-4.22
Diluted EPS	$-1.06	$-1.03	$-4.22
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-74.11M	$-69.39M	$-255.84M
Operating Income / Loss	$-82.77M	$-78.06M	$-285.6M
Cost of Revenue
Net Cash Flow	$320.25M	$23.64M	$-10.53M
PE Ratio